142 related articles for article (PubMed ID: 3990680)
1. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine.
Balzarini J; De Clercq E; Herdewijn P; Robins MJ
Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of 5-nitro-2'-deoxyuridine.
Washtien WL; Santi DV
J Med Chem; 1982 Oct; 25(10):1252-5. PubMed ID: 6183429
[TBL] [Abstract][Full Text] [Related]
3. 5-Substituted 2'-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase.
Balzarini J; De Clercq E; Mertes MP; Shugar D; Torrence PF
Biochem Pharmacol; 1982 Nov; 31(22):3673-82. PubMed ID: 7181950
[TBL] [Abstract][Full Text] [Related]
4. 5-Nitro-2'-deoxyuridine and 5-nitro-2'-deoxyuridine 5'-monophosphate: antiviral activity and inhibition of thymidylate synthetase in vivo.
De Clercq E; Descamps J; Huang GF; Torrence PF
Mol Pharmacol; 1978 May; 14(3):422-30. PubMed ID: 661811
[No Abstract] [Full Text] [Related]
5. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
[TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth.
De Clercq E; Balzarini J; Torrence PF; Mertes MP; Schmidt CL; Shugar D; Barr PJ; Jones AS; Verhelst G; Walker RT
Mol Pharmacol; 1981 Mar; 19(2):321-30. PubMed ID: 7231392
[No Abstract] [Full Text] [Related]
7. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors.
Balzarini J; de Clercq E; Ayusawa D; Seno T
FEBS Lett; 1984 Jul; 173(1):227-32. PubMed ID: 6745430
[TBL] [Abstract][Full Text] [Related]
8. Effect of methotrexate on thymidylate synthetase in cultured parenchymal cells isolated from regenerating rat liver.
Bonney RJ; Maley F
Cancer Res; 1975 Aug; 35(8):1950-6. PubMed ID: 1170938
[TBL] [Abstract][Full Text] [Related]
9. Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
Emura T; Nakagawa F; Fujioka A; Ohshimo H; Kitazato K
Oncol Rep; 2004 Feb; 11(2):381-7. PubMed ID: 14719072
[TBL] [Abstract][Full Text] [Related]
10. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 5-selenium-substituted uracil derivatives. Inhibition of thymidylate synthetase by 5-hydroseleno-2'-deoxyuridylate.
Choi S; Kalman TI; Bardos TJ
J Med Chem; 1979 Jun; 22(6):618-21. PubMed ID: 110931
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
Roberts D; Franklin P; Odom G; Peck C; Chwang TL
Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
[TBL] [Abstract][Full Text] [Related]
14. Role of thymidylate synthetase in the cytostatic activity of pyrimidine nucleoside analogues.
Balzarini J
Bull Mem Acad R Med Belg; 1985; 140(11):432-40. PubMed ID: 3841831
[No Abstract] [Full Text] [Related]
15. Cytotoxicity of 5-nitro-2'-deoxyuridine by in vivo inhibition of thymidylate synthetase.
Washtien W; Matsuda A; Wataya Y; Santi DV
Biochem Pharmacol; 1978; 27(22):2663-6. PubMed ID: 215163
[No Abstract] [Full Text] [Related]
16. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
[TBL] [Abstract][Full Text] [Related]
17. Perspective on the design and biochemical pharmacology of inhibitors of thymidylate synthetase.
Santi DV
J Med Chem; 1980 Feb; 23(2):103-11. PubMed ID: 6987403
[No Abstract] [Full Text] [Related]
18. 5-Formyl-2'-deoxyuridine: cytostatic and antiviral properties and possible modes of action.
Langen P; Waschke SR; Waschke K; Bärwolff D; Reefschläger J; Schulz P; Preussel B; Lehmann C
Acta Biol Med Ger; 1976; 35(12):1625-33. PubMed ID: 195429
[TBL] [Abstract][Full Text] [Related]
19. Antiviral, antitumor, and thymidylate synthetase inhibition studies of 5-substituted styryl derivatives of 2'-deoxyuridine and their 5'-phosphates.
De Clercq E; Balzarini J; Descamps J; Bigge CF; Chang CT; Kalaritis P; Mertes MP
Biochem Pharmacol; 1981 Mar; 30(5):495-502. PubMed ID: 6261769
[No Abstract] [Full Text] [Related]
20. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]